Article
Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing
19 Jun 2020
Abstract excerpt
Twenty years after landmark publications, there is a consensus that the somatic hypermutation (SHM) status of the clonotypic immunoglobulin heavy variable (IGHV) gene is an important cornerstone for accurate risk stratification and therapeutic decision-making in patients with chronic lymphocytic leukemia (CLL). The IGHV SHM status has traditionally been determined by conventional Sanger sequencing. However, NGS...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
